# An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

> **NCT03988855** · PHASE2 · UNKNOWN · sponsor: **Deinove** · enrollment: 40 (estimated)

## Conditions studied

- Clostridium Difficile (C. Difficile)

## Interventions

- **DRUG:** DNV3837

## Key facts

- **NCT ID:** NCT03988855
- **Lead sponsor:** Deinove
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-02
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03988855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03988855, "An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03988855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*